Theratechnologies Inc. reaffirming earnings guidance for the fiscal year 2024. For the year, the company expects revenue guidance range is confirmed between $87 million and $90 million as compared to the 2023 fiscal year results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 CAD | +1.13% | -3.24% | -16.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.36% | 59.81M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-16.48% | 31.47B | |
+53.74% | 25.24B | |
-13.58% | 15.82B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+4.72% | 8.84B | |
-2.11% | 7.93B |
- Stock Market
- Equities
- TH Stock
- News Theratechnologies Inc.
- Theratechnologies Inc. Re-Affirms Earnings Guidance for the Fiscal Year 2024